Escalating prevalence of diabetes and obesity, growing geriatric population and technological advances in tubeless insulin delivery should drive the market size. According to WHO, diabetes will be the among the leading causes of death by 2029. These factors will prominently intensify the global usage of tubeless insulin pump over the forecast period. Lifestyle changes shall continue to impact obesity prevalence in western as well as non-western population. Cultural switch from native diets to high fatty diet should increase the propensity to get affected by diabetes and obesity surging up demand for the tubeless insulin pump.